Horizon Therapeutics Public Limited Company (HZNP) financial statements (2021 and earlier)

Company profile

Business Address CONNAUGHT HOUSE, 1ST FLOOR
DUBLIN, 4
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,076959751509860219
Cash and cash equivalents1,076959751509860219
Restricted cash and investments437721
Receivables40946536730621078
Inventory, net of allowances, customer advances and progress billings5451621751817
Inventory5451621751817
Prepaid expense136 2681
Advances on inventory purchases31     
Other undisclosed current assets100654323813
Total current assets:1,6861,5481,2301,0461,106329
Noncurrent Assets
Operating lease, right-of-use asset40
Property, plant and equipment30202023147
Intangible assets, net (including goodwill)2,1162,5522,8763,2191,943771
Goodwill414426426446254 
Intangible assets, net (excluding goodwill)1,7032,1252,4492,7731,689771
Deferred costs     11
Deferred income tax assets18
Other noncurrent assets4823362912
Other undisclosed noncurrent assets497331(5)(11)
Total noncurrent assets:2,7502,5982,9363,2461,961790
TOTAL ASSETS:4,4364,1464,1664,2923,0671,119
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities257236173235117102
Accounts payable223035521721
Accrued liabilities23520613818310047
Employee-related liabilities     21
Taxes payable     13
Interest and dividends payable     1
Debt4 118448
Liability for uncertainty in income taxes22    
Deferred revenue and credits7311
Other undisclosed current liabilities46052456736023564
Total current liabilities:723762757606358216
Noncurrent Liabilities
Long-term debt and lease obligation1,3991,8971,8911,800857297
Long-term debt, excluding current maturities1,3531,8971,8911,800857297
Operating lease, liability47
Liabilities, other than long-term debt1021672493611389
Deferred revenue and credits10898
Deferred compensation liability, classified138731 
Deferred tax liabilities, net94158297113 
Liability for uncertainty in income taxes910685 
Other liabilities8055684691
Other undisclosed noncurrent liabilities2626727826140156
Total noncurrent liabilities:1,5272,3302,4182,4221,396363
Total liabilities:2,2513,0923,1753,0281,754579
Stockholders' equity
Stockholders' equity attributable to parent2,1851,0549911,2641,313540
Common stock000000
Treasury stock, value(5)(5)(5)(5)(5)(5)
Additional paid in capital2,7982,3752,2492,1192,0021,270
Accumulated other comprehensive loss(2)(2)(1)(3)(3)(4)
Accumulated deficit(606)(1,315)(1,252)(848)(681)(721)
Total stockholders' equity:2,1851,0549911,2641,313540
TOTAL LIABILITIES AND EQUITY:4,4364,1464,1664,2923,0671,119

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues1,3001,2081,056981757297
Revenue, net1,056981757297
Cost of revenue
(Cost of Goods and Services Sold)
(362)(422)(546)(393)(220)(77)
Gross profit:938785510588538220
Operating expenses(811)(783)(902)(735)(482)(229)
Operating income (loss):1272(392)(147)55(8)
Nonoperating expense(147)(122)(121)(81)(188)(261)
Interest and debt expense(59)   (9)(36)
Other undisclosed income from continuing operations before equity method investments, income taxes59   936
Loss from continuing operations before income taxes:(20)(119)(513)(228)(133)(270)
Income tax benefit59345103611726
Net income (loss) available to common stockholders, basic:573(74)(411)(167)40(264)
Dilutive securities, effect on basic earnings per share595     
Net income (loss) available to common stockholders, diluted:1,168(74)(411)(167)40(264)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):573(74)(411)(167)40(264)
Other comprehensive income (loss)(0)(1)2(0)2(2)
Comprehensive income (loss), net of tax, attributable to parent:573(75)(408)(167)41(266)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: